Wells Fargo & Company Glaukos Corp Transaction History
Wells Fargo & Company
- $434 Billion
- Q3 2024
A detailed history of Wells Fargo & Company transactions in Glaukos Corp stock. As of the latest transaction made, Wells Fargo & Company holds 25,120 shares of GKOS stock, worth $3.54 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,120
Previous 24,329
3.25%
Holding current value
$3.54 Million
Previous $2.88 Million
13.65%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding GKOS
# of Institutions
340Shares Held
47.1MCall Options Held
132KPut Options Held
188K-
Black Rock Inc. New York, NY8.04MShares$1.13 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.87MShares$827 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.18MShares$308 Million0.05% of portfolio
-
State Street Corp Boston, MA1.95MShares$275 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.64MShares$231 Million0.06% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $6.7B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...